Ausgangslage
Medisorb manufacturers proven pharmaceuticals and improves healthcare by making efficient medication affordable.
We successfully brought together the Russian family-run pharmaceutical company Medisorb with CapMan, a Finnish private equity fund worth 2.8 billion euros. CapMan’s minority interest enabled Medisorb to triple its production capacity and grow from being the largest maker of generic drugs in the region of Perm to being the largest in Russia.
